Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.
Click to see more
Moderna, Inc. Details
Operating Status:Active
Business TypePublic
HeadquartersCambridge, Massachusetts, United States
Besides the European Commission that just inked a deal with Moderna, the US ranks as one that has shown the highest commitment to both the vaccine development and its acquisition upon approval.
AstraZeneca and the University of Oxford said that their COVID-19 vaccine candidate is cheaper for production and easier for distribution over its rivals. Also, the market cheered on Yellen news as she oversaw a solid economic expansion during her tenure as the former Federal Reserve Chain between 2014-2018.
At Coinspeaker we use cookies in order to improve site performance, offer you a better browsing experience and enable you to easily share content.AcceptPrivacy policy
